Accure Health Inc.
Cambridge, MA Doing business as Accure Health Inc.
- UEI
- P3WPT73RFXZ3
- CAGE
- 7RU76
- Primary NAICS
- 334516 Analytical Laboratory Instrument Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 72 Prince St, Cambridge, MA 02139, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| AI-powered engineering and analysis of cyanobacterium vesicles targeting gastrointestinal cancer - AI-powered… | National Cancer Institute | $400,000 | |
| Automated plasma EV-PDL1 analysis for cancer immunotherapy - abstract challenges. There are over 4000 clinical trials… | National Cancer Institute | $799,826 | |
| Magneto-electronic sensing of cancer in urine | National Cancer Institute | $220,000 |
About Accure Health Inc.
Accure Health Inc., based in Cambridge, Massachusetts, is a for-profit biotech company that develops AI-powered drug-delivery platforms and extracellular-vesicle diagnostic assays for cancer treatment, operating as a federal grant recipient under the National Cancer Institute (100% of federal awards). The vendor has no federal contract footprint; all federal engagement flows through the National Institutes of Health.
Accure's capability portfolio centers on precision oncology therapeutics and biomarker analysis. As prime recipient on a $400,000 Phase I Project Grant from the National Cancer Institute (CFDA 93.395) running through August 31, 2026, Accure is engineering AI-designed membrane vesicles derived from the cyanobacterium Spirulina to enable targeted oral delivery of RNA therapeutics to CLDN18.2-positive gastrointestinal cancers, addressing the 75-80% clinical failure rate caused by ineffective in vivo drug delivery. Accure previously completed a Project Grant from the National Cancer Institute (award date September 19, 2022, completion August 31, 2024) to develop an automated magneto-electronic sensing (TIMES) assay platform for analyzing circulating PD-L1 biomarkers in extracellular vesicles, intended to improve patient selection for anti-PD-1/PD-L1 immunotherapy trials as an alternative to tissue-biopsy-based tumor proportion scoring.
The vendor also acts as a sub-recipient on a collaborative federal grant awarded to The General Hospital Corporation (award date January 22, 2026), providing technical support for the next-generation iMEX (TIMES) instrument, manufacturing EV isolation cartridges and electrochemical-sensor chips, and screening extracellular vesicles from cell cultures for ovarian cancer biomarkers.
All four federal awards (100% coverage) originate from the National Cancer Institute. The vendor's federal footprint is sparse and nascent — one award per year across 2017, 2022, 2025, and 2026 — with $1.6 million combined obligation. One award (the current $400,000 TIMES Phase I grant) reaches ultimate completion within the next twenty-four months and faces potential recompete renewal or successor-phase funding.
Quick answers
What is Accure Health Inc.'s UEI?
Accure Health Inc.'s Unique Entity ID (UEI) in SAM.gov is P3WPT73RFXZ3.
What is Accure Health Inc.'s CAGE code?
Accure Health Inc.'s CAGE code is 7RU76.
What is Accure Health Inc.'s primary NAICS code?
Accure Health Inc.'s primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).
Where is Accure Health Inc. located?
Accure Health Inc.'s physical address in SAM.gov is 72 Prince St, Cambridge, MA 02139, USA.
Is Accure Health Inc. registered in SAM.gov?
Yes. Accure Health Inc.'s SAM.gov registration is active through April 14, 2027.
What is Accure Health Inc.'s most recent federal award?
Accure Health Inc.'s most recent federal grant award is AI-powered engineering and analysis of cyanobacterium vesicles targeting gastrointestinal cancer - AI-powered… (R43CA298194), from National Cancer Institute, on September 1, 2025.
On GovTribe
See Accure Health Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors